Pyrazinamide May Improve Fluoroquinolone-Based Treatment of Multidrug-Resistant Tuberculosis

The role of pyrazinamide in the current treatment of multidrug-resistant (MDR) tuberculosis (TB) is uncertain. From a territory-wide registry of MDR-TB cases diagnosed between 1995 and 2009, we assembled a cohort of 194 patients with MDR pulmonary TB given fluoroquinolone-containing regimens. Strati...

詳細記述

保存先:
書誌詳細
主要な著者: Chang, Kwok-Chiu, Leung, Chi-Chiu, Yew, Wing-Wai, Leung, Eric Chung-Ching, Leung, Wai-Man, Tam, Cheuk-Ming, Zhang, Ying
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Microbiology 2012
主題:
Clinical Therapeutics
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3486566/
https://ncbi.nlm.nih.gov/pubmed/22869570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01300-12
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料